RecruitingPhase 3NCT01696734

Domperidone in Treating Patients With Gastrointestinal Disorders

Treatment Protocol for the Compassionate Use of Domperidone

Sponsor

M.D. Anderson Cancer Center

Enrollment

200 participants

Start Date

Oct 23, 2012

Study Type

INTERVENTIONAL

Conditions

Nausea and Vomiting Gastroparesis Dyspepsia Gastroesophageal Reflux Disease Esophagitis Digestive System Disorder Heartburn

Summary

This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Domperidone and Questionnaire Administration for people with digestive system disorder, dyspepsia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.